News
UK postcode lottery ends for 'life-changing' cystinosis drug
Patients in England with rare disease cystinosis will soon be able to access a drug that has been available in other UK nations for up to three years
News
Are we about to see a return for the pharma mega-merger?
There are rumours that the first pharma 'mega-merger' for several years – between AstraZeneca and Bristol Myers Squibb – is under discussion.
News
Datroway joins Trodelvy for frontline TNBC in the EU
AstraZeneca and Daiichi Sankyo's Datroway enters the first-line triple-negative breast cancer market in the EU, taking on Gilead's Trodelvy.
News
Adcomm backs Replimune melanoma drug, despite data concern
Replimune's RP1 immunotherapy for melanoma clears advisory committee vote by 10 to three, despite FDA concerns about the design of the IGNYTE study.
Market Access
Policy in Focus: What’s new with CMS drug price negotiation,...
Hogan Lovells partner Alice Valder Curran returned to elucidate some of the finer points of the latest communication from CMS.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
